EFOI Q4 2024 Earnings Narrowed Loss Amid Continued Strategic Restructuring Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue CZR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Rises Despite Wider Loss Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus BLNE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines SBS Q1 2026 Earnings Modest EPS Beat Amidst Operational Efficiency Gains